Author

P. J. Skinner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Assay:flow cytometry· 1 Organism:non-human primate· 1 Organism:rat· 1

Frequent Co-Authors

A. K. Rendahl· 2 shared E. Connick· 2 shared E. G. Rakasz· 2 shared A. E. Golfinos· 1 shared A. J. Balgeman· 1 shared A. J. Weaver· 1 shared A. L. Ellis-Connell· 1 shared A. M. Weiler· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. K. Rendahl

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Transient T cell expansion, activation, and proliferation in therapeutically vaccinated SIV+ macaques treated with N-803

O. E. Harwood, A. J. Balgeman, A. J. Weaver, A. L. Ellis-Connell, A. M. Weiler, K. N. Erickson, L. M. Matschke, A. E. Golfinos, V. Vezys, P. J. Skinner, J. T. Safrit, P. T. Edlefsen, M. R. Reynolds, T. C. Friedrich, S. L. O'Connor

This study shows that therapeutic vaccination with a heterologous prime-boost regimen followed by N-803 treatment enhances CD8+ T cell responses in SIV-infected macaques.

bioRxiv · Jul 8, 2022 · PreprintImmunology

CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection

M. S. Pampusch, H. M. Abdelaal, E. K. Cartwright, J. S. Molden, B. C. Davey, J. D. Sauve, A. K. Rendahl, E. G. Rakasz, E. Connick, E. A. Berger, P. J. Skinner

This study evaluates CAR/CXCR5-T cell therapy in SIV-infected rhesus macaques, showing reduced viral loads and safety, with potential for HIV remission.

bioRxiv · Jul 26, 2021Immunology

Absence of SIV-specific CD8+ T cells in germinal centers may set the stage for persistent infection

S. Li, J. M. Folkvord, K. J. Kovacs, R. K. Wagstaff, G. Mwakalundwa, A. K. Rendahl, E. G. Rakasz, E. Connick, P. J. Skinner

The paper shows that SIV-specific CD8+ T cells are excluded from germinal centers early in infection, potentially contributing to persistent viral infection.

bioRxiv · Sep 3, 2018Immunology